Home > Back to Publisher > Report Information

Medical Imaging Markets

TriMark Publications
May 1, 2011
239 Pages - SKU: TRI6276731

Abstract Table of Contents Related Reports

The purpose of this TriMark Publications report is to describe the specific market segment of the diagnostics market sector called medical imaging. Medical imaging can be categorized into nine main modalities: X-ray, ultrasound, computed tomography (CT), positron emission tomography (PET), single photon emission tomography (SPECT), magnetic resonance imaging (MRI), nuclear medicine (NM), mammography and fluoroscopy. Globally, X-ray is the most frequently used imaging procedure with about 108 million X-ray exams per year. MRI is second with 26 million examinations per year. PET, SPECT, CT and nuclear medicine rank third with 30 million examinations per year.

Picture archiving and communication systems (PACS) and contrast agents are the sub-segments in medical imaging market that have gained significant growth in recent years. As a result of these medical imaging advancements, the multi-slice systems are generating large volumes of data, and this creates demand for data storage, 3-D visualization and analysis. As such, the global medical imaging industry is primed to experience significant growth through the next decade. This report surveys almost all of the companies known to be marketing, manufacturing or developing medical imaging equipment and supplies in the world. Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position. Detailed tables and charts with sales forecasts and market share data are also included.

Additional Information

Press Release

New York, NY, March 14, 2011 - TriMarkPublications.com cites in its newly published “Medical Imaging Markets” report that global spending on medical imaging equipment exceeded $21 billion in 2010.

Medical imaging can be categorized into nine main modalities: X-ray, ultrasound, computed tomography (CT), positron emission tomography (PET), single photon emission computed tomography (SPECT), magnetic resonance imaging (MRI), nuclear medicine, mammography and fluoroscopy. Globally, X-ray is the most used imaging procedure with about 108 million X-ray exams per year. MRI is second with 26 million examinations per year. PET, SPECT, CT and nuclear medicine rank third with 30 million examinations per year. Picture archiving and communication systems (PACS) and contrast agents are the sub-segments in medical imaging market that have gained significant growth in recent years. As such, the global medical imaging industry is primed to experience significant expansion throughout the decade.

The “Medical Imaging Markets” report covers:

Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Positron Emission Tomography (PET)
Single-Photon Emission Computed Tomography (SPECT)
Hybrid Modalities
Mammography
Digital Radiography/Computed Radiography (DR/CR)
Image-Guided Radiation Therapy (IGRT)
Cardiac CT Imaging
CT Angiography
Nuclear Medicine in Cardiac Imaging
MRI vs. SPECT in Cardiac Procedures
Echocardiography in Cardiac Imaging
Optical Coherence Tomography (OCT)

The “Medical Imaging Markets” report examines companies manufacturing medical imaging equipment and supplies in the world. Companies covered include: 3mensio Medical, Agfa HealthCare, Analogic, Ardent Sound, Avreo, Biosound Esaote, BK Medical, BRIT Systems, Canon, Focus Surgery, Fonar, Fujifilm, Fukuda Denshi, GE Healthcare, Hitachi Medical, Hologic, InfiMed, Intelerad, Konica Minolta, Lantheus, Lumedx, Median, Medis, Medison, Medtronic, NanoScan, NovaRad, Phantom Laboratory, Philips Healthcare, Sectra Medical, Schick Technologies, ScImage, Siemens Healthcare, Shimadzu, SonoSite, Spacelabs Healthcare, Syntermed, TeraMedica, TeraRecon, TomTec Imaging, Toshiba, UltraRAD, Varian, Vepro, Vidar Systems, Vital Images, VuCOMP and Xoran.

1. Overview: 1.1 Statement of Report; 1.2 Scope of this Report; 1.3 Methodology; 1.4 Executive Summary; 1.5 Market Drivers in Medical Imaging; 1.6 Challenges in Medical Imaging
2. Medical Imaging Technologies: A Brief Overview: 2.1 General X-rays in Medical Imaging; 2.4 Positron Emission Tomography (PET); 2.5 Single Photon Emission Computed Tomography (SPECT); 2.6 Ultrasound (US); 2.7 Mammography
3. Market Analysis: 3.1 Medical Imaging and Information Technology Industry; 3.2 Medical Imaging: Revenue Scenario in 2009; 3.3 Popular Imaging Systems in 2009; 3.4 Spending in IT Infrastructure; 3.5 Global Market for Medical Imaging; 3.6 Global Market for General X-Rays; 3.7 Global Market for Ultrasound (US); 3.8 Global Market for Magnetic Resonance Imaging (MRI); 3.9 Global Market for Computed Tomography (CT); 3.10 Global Market for Cardiovascular X-Ray; 3.11 Global Market for Nuclear Medicine; 3.12 Global Market for PET/CT; 3.13 Global Oncology Biomarkers Market; 3.15 Global Medical Displays and Post-Processing Software Market; 3.16 Global Market for Connectors in the Medical Electronics Market; 3.17 North American Market for Medical Imaging; 3.18 Radiology Practice in the U.S.; 3.19 U.S. Market for Brachytherapy Products; 3.23 U.S. Market for Healthcare IT; 3.24 Medical Imaging in Canada; 3.25 Medical Imaging in Europe; 3.26 Emerging Markets in Medical Imaging; 3.27 Medical Imaging Market in China; 3.28 Medical Imaging Market in India
4. Funding Arrangements for Medical Imaging Procedures: 4.1 The Working of the Systems
5. Health and Medical Imaging Expenditures in OECD Countries: 5.1 Diagnostic Imaging Equipment and Utilization Statistics; 5.2 Utilization of Medical Imaging Modalities in OECD Countries
6. Company Profiles: 6.1 3mensio Medical Imaging BV; 6.2 Agfa HealthCare; 6.3 Analogic Corporation; 6.4 Ardent Sound, Inc; 6.5 Avreo, Inc.; 6.6 Bard Access Systems, Inc.; 6.7 Biosound Esaote, Inc,; 6.8 BK Medical; 6.9 BRIT Systems, Inc.; 6.10 Canon U.S.A., Inc.; 6.11 Candelis; 6.12 Cedaron Medical, Inc.; 6.13 Chison Medical Imaging, Co., Ltd.; 6.14 DR Systems, Inc.; 6.15 Focus Surgery, Inc.; 6.16 Fonar Corporation; 6.17 Fujifilm Medical Systems USA, Inc.; 6.18 Fukuda Denshi Co., Ltd.; 6.19 GE Healthcare; 6.20 Hitachi Medical Corporation; 6.21 Hermes Medical Solutions; 6.22 Hologic, Inc.; 6.23 Imaging Diagnostic Systems, Inc.; 6.24 InfiMed, Inc.; 6.25 InSite One, Inc.; 6.26 Intelerad Medical Systems; 6.27 Konica Minolta Medical Imaging USA, Inc.; 6.28 Lantheus Medical Imaging, Inc.; 6.29 Lumedx; 6.30 MEDIAN Technologies S.A.; 6.31 Medis Medical Imaging Systems BV; 6.32 Medison America, Inc.; 6.33 Medtronic, Inc.; 6.34 NanoScan Imaging, LLC; 6.35 NovaRad; 6.36 The Phantom Laboratory; 6.37 Philips Healthcare; 6.38 Sectra Medical Systems S.L.; 6.39 Schick Technologies, Inc.; 6.40 ScImage, Inc.; 6.41 Siemens Healthcare; 6.42 Shimadzu Corporation; 6.43 SonoSite, Inc.; 6.44 Spacelabs Healthcare, Inc.; 6.45 Syntermed, Inc.; 6.46 TeraMedica, Inc.; 6.47 TeraRecon, Inc.; 6.48 TomTec Imaging Systems GmbH; 6.49 Toshiba America Medical Systems, Inc.; 6.50 UltraRAD Corporation; 6.51 Varian Medical Systems, Inc.; 6.52 Vepro; 6.53 Vidar Systems Corporation; 6.54 Vital Images, Inc; 6.55 VuCOMP, Inc.; 6.56 Xoran Technologies, Inc.; Appendix 1: Medical Imaging Technologies; Appendix 1.1: Ultrasound Systems; Appendix 1.2: Computed Tomography; Appendix 1.3: Magnetic Resonance Imaging (MRI); Appendix 1.4: Digital X-Ray; Appendix 1.5: Positron Emission Tomography (PET); Appendix 2: Current and Future Trends in Medical Imaging Electronics; Appendix 2.1: Power Management; Appendix 2.2: Miniaturization and Integration; Appendix 3: Supply of Medical Radioisotopes; Appendix 3.1: Potential for New Reactors; Appendix 3.2: Processing Capacities and Restraints; Appendix 4: Opportunities in the Middle East for Healthcare and Medical Imaging Products; Appendix 4.1: The Largest U.S. Customers in the Middle East Region; Appendix 4.2: U.S. Exports of Medical Imaging Products to the Middle East; Appendix 5: Value of Radiation Therapy and Medical Imaging; Appendix 5.1: Effective Use of Medical Radiation; Appendix 5.2: Innovations to Reduce Radiation Dose; Appendix 5.3: Innovations in CT Imaging; Appendix 5.4: Effectiveness of Radiation Therapy; Appendix 5.5: Efforts to Minimize Radiation Dose; Appendix 5.6: New Dose Check Features

INDEX OF FIGURES

Figure 1.1: Major Drivers of Healthcare Costs in the U.S., 2010

Figure 1.2: Growth in Medicare Allowed Services and Charges for Medical Imaging in the U.S., 1995-2009

Figure 1.3: Hospital Imaging Volume Projections in the U.S., 2005-2015

Figure 3.1: Medical Imaging Markets by Region, 2009

Figure 3.2: Global Medical Imaging Market by Modality, 2009

Figure 3.3: Global Market for General X-Rays, 2009-2016

Figure 3.4: Global Market for Ultrasound, 2009-2016

Figure 3.5: Global Market for Portable Ultrasound Equipment, 2009-2014

Figure 3.6: Global Magnetic Resonance Imaging (MRI) Market by Geography, 2010

Figure 3.7: Global Market for MRI, 2009-2016

Figure 3.8: Global CT Market, 2004-2009

Figure 3.9: Global Market for Computed Tomography, 2009-2016

Figure 3.10: Global Market for Cardiovascular X-Ray, 2009-2016

Figure 3.11: Market for Nuclear Medicine, 2009-2016

Figure 3.12: Estimated Lifetime Risks for Alzheimer's by Age and Sex in the U.S.

Figure 3.13: Global Market for SPECT/PET, 2010-2015

Figure 3.14: Global Market for PET/CT, 2010-2015

Figure 3.15: Global Market for Biomarkers, 2009-2014

Figure 3.16: Biomarker Patent Filings by Type of Cancer, 2010

Figure 3.17: Global Market for Breast Cancer, 2009-2016

Figure 3.18: Global Market for Medical Displays and Post-Processing Software, 2009-2014

Figure 3.19: Global Market for Connectors in the Medical Electronics, 2009-2014

Figure 3.20: North American Market for Medical Imaging Equipment, 2009-2016

Figure 3.21: North American Market for Magnetic Resonance Imaging, 2010-2015

Figure 3.22: U.S. Market for Computed Tomography (CT), 2008-2015

Figure 3.23: Market for Multi Slice CT Systems in the U.S., 2008-2015

Figure 3.24: U.S. Market for Radiopharmaceuticals, 2009-2017

Figure 3.25: U.S. Market for SPECT, 2009-2017

Figure 3.26: U.S. Market for PET, 2009-2017

Figure 3.27: U.S. Market for Brachytherapy Products, 2008-2016

Figure 3.28: New Breast Cancer Incidence in North America, 2009-2017

Figure 3.29: U.S. Market for Mammography, 2008-2013

Figure 3.30: U.S. Market for Partial Breast Irradiation, 2008-2016

Figure 3.31: Age-Specific Death Rates Due to Breast Cancer by Age Group, U.S., 1996 and 2006

Figure 3.32: U.S. Market for Irradiated Microspheres for Liver Cancer, 2008-2016

Figure 3.33: Age-Specific Incidence Rate of Breast Cancer in U.K., 2007

Figure 3.34: U.S. Market for PACS, 2008-2015

Figure 3.35: Number of U.S. Hospitals with PACS Installed, 2000-2008

Figure 3.36: Number of U.S. Hospitals with Installed PACS, 2000-2008

Figure 3.37: Replacements and New PACS Purchases, 2000-2008

Figure 3.38: PACS Installation by Bed Size in the U.S., 2000-2008

Figure 3.39: PACS Modalities Installations in the U.S. Hospitals, 2005 and 2008

Figure 3.40: PACS Company Market Share, 2008

Figure 3.41: PACS Image Distribution in Hospital Departments, 2006-2008

Figure 3.42: PACS Images Accessibility by Physician, 2006-2008

Figure 3.43: RIS and PACS Interface, 2005-2008

Figure 3.44: U.S. Market for Healthcare IT, 2009-2014

Figure 3.45: U.S. Market for Software Applications, 2009-2014

Figure 3.46: Canadian Market for Medical Imaging Modalities, 2009-2014

Figure 3.47: Percent Distribution of Diagnostic Imaging Examinations in Canadian Hospitals, 2006

Figure 3.48: Medical Imaging Market Leaders and their Market Share in Canada, 2009

Figure 3.49: Types and Breakdown of Nuclear Medicine Procedures that Can be DoneUsing Tc-99m

Figure 3.50: Global Nuclear Medicine Market Share by Reactor, 2008

Figure 3.51: Percent Global Market for Tc-99m by Geography/Country and Doses

Figure 3.52: Western European Market for Medical Imaging Equipment, 2009-2016

Figure 3.53: Imaging Diagnostics Market in Central Europe, 2009-2012

Figure 3.54: European Market for PACS, 2009-2016

Figure 3.55: European Market for Digital Radiography, 2009-2016

Figure 3.56: European Market for Computed Radiography, 2009-2016

Figure 3.57: European Market for Magnetic Resonance Imaging (MRI), 2010-2015

Figure 3.58: Percentage of Causes of Death in Women

Figure 3.59: Diagnostic Imaging Market in Emerging Markets, 2009-2016

Figure 3.60: Diagnostic Imaging Equipment Installations in the Two Emerging Economies, 2009

Figure 3.61: Middle-class population as a % of the total population in India, 1998-2010

Figure 3.62: Market for Medical Imaging Equipment in Greater China, 2009-2016

Figure 3.63: Market for Ultrasound in China, 2009-2014

Figure 3.64: Market for Medical Imaging Equipment in India, 2009-2016

Figure 3.65: Number of MRI Units in India, 2009

Figure 3.66: Indian CT Systems Market by Value, 2009

Figure 3.67: Indian CT Systems Market by Unit, 2009

Figure 3.68: Market for X-Ray in India, 2006-2009

Figure 3.69: Indian X-Ray Equipment Market by Unit (%), 2009

Figure 3.70: Indian Market for Cath Labs by Value, 2008-2009

Figure 3.71: Indian Cath Lab Market by Units, 2008-2009

Figure 3.72: Indian Ultrasonic Equipment Market Share by Segment, 2007

Figure 3.73: Percent Indian Market Share in Endoscopy by Segment, 2009

Figure 3.74: Indian Market for PET Systems and Gamma Camera, 2009

Figure 5.1: Public and Private Expenditure on Health % of GDP in Select OECD Countries

Figure 5.2: Angiography Units per Million of Population in OECD Countries

Figure 5.3: CT Scanners per Million of Population in OED Countries

Figure 5.4: Gamma Cameras per Million of Population in OECD Countries

Figure 5.5: Mammography Units per Million of Population in OECD Countries

Figure 5.6: MRI Scanners per Million of Population in OECD Countries

Figure 5.7: PET Scanners per Million of Population in OECD Countries

Figure 5.8: CT Exams per Scanner in OECD Countries

Figure 5.9: CT Exams per 1,000 of Population in OECD Countries

Figure 5.10: MRI exams per Scanner in the OECD countries

Figure 5.11: MRI Exams per 1,000 of Population in OECD Countries

Figure App. 1.1: Block Diagram of Imaging Ultrasound Equipment

Figure App. 1.2: Block Diagram of a Medical CT System

Figure App. 1.3: Block Diagram of a Medical MRI

Figure App 1.4: Block Diagram of Digital X-Ray

Figure App. 1.5: Block Diagram for Positron Emission Tomography

Figure App 2.1: Block Diagram of Portable Ultrasound System

Figure App. 3.1: Current Supply and Demand for Medical Radioisotopes, 2010-2024

Figure App. 3.2: Percent Market Share of Medical Radioisotopes by Reactor, 2010

Figure App. 4.1: U.S. Exports of Medical Products to the Middle East, 1996-2009

Figure App. 4.2: U.S. Exports of Medical Products to Israel, Saudi Arabia and

Turkey, 1996-2009

Figure App. 4.3: U.S. Exports of Medical Imaging Products to Israel, Saudi

Arabia and Turkey, 1996-2009

INDEX OF TABLES

Table 1.1: Code-Specific Impacts of CMS Medicare Physician Fee Schedule

Table 1.2: CT Technical Revenue: Breakeven at Various Levels of Utilization in the U.S.

Table 1.3: MRI Technical Revenue: Breakeven at Various Levels of Utilization in the U.S.

Table 1.4: Reimbursement Reductions and Effect on Contribution Margin in U.S. Outpatient Imaging

Table 2.1: Properties of Scintillation Crystals in PET Imaging Systems

Table 2.2: Radioisotopes Used in Medical Imaging

Table 2.3: Comparative Data on X-Ray Contrast Media

Table 2.4: Properties of Low and Iso-Osmolar Contrast Agents

Table 2.5: A Sample of Common Radiological Contrasting Agents and Discount Rates

Table 2.6: Common MRI Contrast Agents and Discount Rates

Table 2.7: Common Ultrasound Contrast Agents and Discount

Table 3.1: Top Ten Imaging Systems Purchased, 2006-2009

Table 3.2: IT Spending in the U.S. Hospitals, 2010-2015

Table 3.3: Biomarkers Used in Cancer Diagnosis

Table 3.4: Medicare Payment Rated for SPECT/CT Procedures in the U.S., 2010

Table 3.5: Medicare Reimbursement for PET Services in the U.S., 2010

Table 3.6: Female Breast Cancer Risk Factors

Table 3.7: FDA Approved Mammography Systems, Breast Tests and Breast Implants, 2000-2010

Table 3.8: Medicare Reimbursement for Mammography Procedures, 2009

Table 3.9: Mortality Rate in European Countries, 1989-2006

Table 3.10: Number of New Cases and Rates of Breast Cancer in the U.K., 2007

Table 3.11: Sources of Operating Funds for Medical Imaging Equipment in Canada,

2007

Table 3.12: Canadian Fee Structure for Medical Imaging Procedures

Table 3.13: Imaging Modalities Available in Whitehorse General Hospital

Table 3.14: Imaging Equipment in Watson Lake Hospital and the Health Centers

Table 3.15: Imaging Equipment in Stanton Territorial Hospital

Table 3.16: Diagnostic Imaging Equipment in Northern Territory Hospitals

Table 3.17: Imaging Technologies in the Qikiqtani General Hospital

Table 3.18: Diagnostic Imaging Equipment Installations in China and India,

2000-2009

Table 3.19: Availability of Medical Imaging Equipment per Million Populations in China and India, 2009

Table 3.20: Diagnostic Imaging Affordability in Emerging Economies

Table 3.21: Multinational Firms in China for Medical Imaging Products

Table 3.22: Installed Base of CT and MRI in India, China, Japan and Korea, 2010

Table 3.23: Medical Cyclotrons in India

Table 3.24: PET/CT Scanner Profile in India

Table 3.25: PET/CT Scanners: No. of Slices Used in India

Table 3.26: Imaging Protocols in PET/CT in India

Table 3.27: Drivers of X-Ray Industry in India

Table 3.28: Major Ultrasound Market Vendors in India

Table 3.29: Ultrasound Equipment Vendors in India

Table 4.1: Weeks Waited for Medical Imaging Procedures in Canada

Table 4.2: Reimbursement Rates for Medical Imaging Procedures in Germany

Table 4.3: Reimbursement Rates for Medical Imaging Procedures in New Zealand

Table 4.4: Non-Mandatory Tariffs for Medical imaging in the U.K, 2009-2010

Table 4.5: Number and Cost of Medical Imaging Services in the U.K., 2008-09

Table 4.6: Percent Distribution of Health Services Visit by Expected Source of Payment, U.S.

Table 4.7: Cost of MRI and PET in Different States and Cities in the U.S.

Table 6.1: 3mensio's Product Portfolio

Table 6.2: Agfa's Medical Imaging Products

Table 6.3: Ardent's Product Portfolio

Table 6.4: Avreo's Radiology Workflow Solutions

Table 6.5: Bard's Imaging Products

Table 6.6: Biosound Esaote's Ultrasound Systems

Table 6.7: BK Medical's Product Portfolio

Table 6.8: BRIT System's Healthcare IT Solutions

Table 6.9: Canon's Medical Imaging Products

Table 6.10: Candelis' Software Solutions for Medical Imaging

Table 6.11: Chison's Ultrasound Product Portfolio

Table 6.12: DR System's Healthcare IT Solutions

Table 6.13: Fujifilm Medical Systems' Product Portfolio

Table 6.14: Fakuda's Ultrasound Products

Table 6.15: GE Healthcare's Medical Imaging Modalities and Contrast Media

Table 6.16: Hitachi's Medical Imaging Product Portfolio

Table 6.17: Hermes' Medical Imaging Software Solutions

Table 6.18: InfiMed's Product Portfolio

Table 6.19: InSite One's Software Solutions

Table 6.20: Intelerad's Software Solutions

Table 6.21: Lantheus' Contrast Agent Products

Table 6.22: Lumedx's Cardiovascular Information System Solutions

Table 6.23: Medis' Software for Various Medical Imaging Modalities

Table 6.24: Medison's Medical Imaging Products

Table 6.25: NovaRad's Product Portfolio

Table 6.26: Philips' Computed Tomography Systems

Table 6.27: Philips' Nuclear Medicine Products

Table 6.28: Philips' Radiography Systems

Table 6.29: Philips' Radiography/Fluoroscopy (R/F) Products

Table 6.30: Philips' Magnetic Resonance Imaging (MRI) Systems

Table 6.31: Philips' Mammography Systems

Table 6.32: Spectra's Product Portfolio

Table 6.33: Schick's Product Portfolio in Medical Imaging

Table 6.34: Sclmage's Product Portfolio

Table 6.35: Siemens' Product Portfolio

Table 6.36: Shimadzu's Product Portfolio

Table 6.37: TeraMedica's Portfolio of Solutions and Products

Table 6.38: TeraRecon's Portfolio of Imaging Solutions

Table 6.39: TomTec's Product Portfolio

Table 6.40: UltraRAD's Product Portfolio

Table 6.41: Vepro's Product Portfolio

Table 6.42: Vidar's Product Portfolio

Table 6.43: Vital Images' Product Portfolio

Table App. 3.1: Major Current 99Mo Producing Reactors, 2010

Table App. 3.2: Potential Reactor-Based Projects for 99Mo Production, 2010-2024

Table App. 3.3: Processing Capacity of Major Reactors, 2010

Table App. 3.4: Demand Scenarios for 99Mo, 2010-2025

Share this report

Email a colleague

Other tasks

Research Assistance

Ask a question

Related Markets

Radiography & X-Rays Reports

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!